BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2024 8:41:52 AM | Browse: 80 | Download: 230
 |
Received |
|
2024-05-03 16:24 |
 |
Peer-Review Started |
|
2024-05-03 16:27 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-06-06 02:44 |
 |
Revised |
|
2024-06-22 15:39 |
 |
Second Decision |
|
2024-08-06 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-08-06 06:37 |
 |
Articles in Press |
|
2024-08-06 06:37 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-08-15 17:08 |
 |
Publish the Manuscript Online |
|
2024-08-27 08:41 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cell & Tissue Engineering |
Manuscript Type |
Meta-Analysis |
Article Title |
Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yan Xu, Xue-Song Wang, Xiao-Lei Zhou, Wen-Ming Lu, Xing-Kun Tang, Yu Jin and Jun-Song Ye |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
32060232 |
Jiangxi Provincial Natural Science Foundation |
20212BAB206075 |
|
Corresponding Author |
Jun-Song Ye, PhD, Professor, Teacher, Subcenter for Stem Cell Clinical Translation, First Affiliated Hospital of Gannan Medical University, No. 23 Qingnian Road, Ganzhou 341000, Jiangxi Province, China. yjs1211@163.com |
Key Words |
Mesenchymal stem cell; Stem cell therapy; Liver fibrosis; Combination of drugs; Cirrhosis; Meta-analysis |
Core Tip |
The efficacy of mesenchymal stem cells (MSCs) therapy for hepatic fibrosis is affected by liver colonization rate and low survival rate. In recent years, an increasing number of studies have shown that the combination of MSCs and drugs can improve the efficacy of MSCs alone in treating liver fibrosis. Our Meta-analysis summarizing the current studies and systematically assessed the efficacy of this combined strategy to ameliorate liver fibrosis. |
Publish Date |
2024-08-27 08:41 |
Citation |
<p>Xu Y, Wang XS, Zhou XL, Lu WM, Tang XK, Jin Y, Ye JS. Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies. <i>World J Gastroenterol</i> 2024; 30(32): 3766-3782</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i32/3766.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i32.3766 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345